News Focus
News Focus
Replies to #45605 on Biotech Values
icon url

caravon

04/23/07 4:07 PM

#45606 RE: DewDiligence #45605

It is of interest that, due to its marketing, even AMLN does not know byetta new Rx’s numbers.

AMLN marketing is in a disarray. It is all what is known.
icon url

lumpy9200

04/23/07 5:30 PM

#45608 RE: DewDiligence #45605

AMLN,

As the price of AMLN has recovered of late, I'm becoming tempted to sell the last shares and move on. Pramlintide (Symlin) for weight loss is compelling, which is one of the things that keeps me holding. I have to wonder at this point if LAR will ever be huge, what with the large needle and pending Liraglutide on the horizon.

Best,
Geoff